My watch list  

224 Current news from israel

matching the following criteria

Genmab achieves USD 45 million milestone

Milestone triggered by first commercial sale of DARZALEX in the United States


Genmab A/S announced it has achieved a USD 45 million milestone in its DARZALEX™ (daratumumab) collaboration with Janssen Biotech, Inc. The milestone payment was triggered by the first commercial sale of DARZALEX in the United States. "Today marks a significant moment in the history of Genmab - ...


CMC Biologics appoints new CEO

Gustavo Mahler, COO & President at CMC Biologics, to Take the Helm January 1st 2016


CMC Biologics, Inc. announced the promotion of Gustavo Mahler, to be effective January 1st 2016, to serve as its Chief Executive Officer. Gustavo has more that 20 years of executive management experience in biologics manufacturing and development. Gustavo joined the company as head of the Seattle ...


CHMP grants accelerated assessment for Daratumumab for double refractory multiple myeloma


Genmab A/S announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted accelerated assessment to the Marketing Authorization Application (MAA) for daratumumab.The MAA is for daratumumab as a treatment for patients with relapsed and ...


Ascendis Pharma Announces Positive Top-line Results from a Phase 2 Pediatric Study for the Treatment of Growth Hormone Deficiency


Ascendis Pharma A/S announced positive top-line results from a six-month Phase 2 study to evaluate the safety and efficacy of once-weekly TransCon Growth Hormone in 53 treatment-naïve, pre-pubertal children with growth hormone deficiency, or GHD."We are extremely pleased with the top-line results ...


Genes determine our thirst for coffee

Coffee not associated with lifestyle diseases


We love coffee - and we drink a lot of it. New research from the University of Copenhagen and Herlev and Gentofte Hospital shows that coffee neither increases nor decreases the risk of developing lifestyle diseases such as obesity and diabetes. The researchers have based their study on genes, as ...


Avilex Pharma receives Wellcome Trust Translation Award


Avilex Pharma announces that it has received a 18 million DKK (2.4 million EUR) Translation Award from Wellcome Trust to fund the development of a novel drug candidate for acute treatment of ischemic stroke. Ischemic stroke is a leading cause of death and disability worldwide, with very few ...


Minervax initiates phase I clinical trial with Group B Streptococcal vaccine


MinervaX, a privately held Danish biotech company, announced that the company has initiated a Phase I clinical trial with its Group B Streptococcal (GBS) vaccine candidate, GBS-NN, targeting pregnant women for the prevention of life-threatening infections in newborns. GBS is responsible for 50% ...


Infections can affect your IQ

New research shows that infections can impair your cognitive ability measured on an IQ scale


New research shows that infections can impair your cognitive ability measured on an IQ scale. The study is the largest of its kind to date, and it shows a clear correlation between infection levels and impaired cognition. Anyone can suffer from an infection, for example in their stomach, urinary ...


CMC Biologics Expands GMP Manufacturing Capacity in the United States and Europe

Company plans to add more than 30,000L of bioreactor capacity across its three sites


CMC Biologics, Inc announced a plan to expand its global manufacturing capacity by more than 30,000 liters in the United States and Europe to meet growing customer demands for late-stage and commercial manufacturing."This global expansion addresses increasing demands from our customers for ...


Ascendis Pharma A/S Announces Results of Phase 1 Study of TransCon Treprostinil


Ascendis Pharma A/S announced that its Phase 1 single ascending dose study of TransCon Treprostinil produced dose-dependent increases in plasma treprostinil levels in-line with expectations. However, treprostinil-related injection-site tolerability issues did not meet the criteria defined in ...


Page 1 From 23
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE